Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Ullum

Showing results (31-40 of 76) with videos related to

Pageof 8
Sort By:
HIV Medicine|January 22, 2003
Virological and immunological profiles among patients with undetectable viral load followed prospectively for 24 monthsT L Katzenstein, H Ullum, B T Røge, et al.
HIV Medicine|July 10, 2018
Association between smoking status assessed with plasma-cotinine and inflammatory and endothelial biomarkers in HIV-positive and HIV-negative individualsM G Ahlström, A Knudsen, H Ullum, et al.
BMC Infectious Diseases|October 27, 2009
Downregulation of MIP-1alpha/CCL3 with praziquantel treatment in Schistosoma haematobium and HIV-1 co-infected individuals in a rural community in ZimbabweRbl Zinyama-Gutsire, E Gomo, P Kallestrup, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 6, 2018
The neutrophil-to-lymphocyte ratio is associated with multiple sclerosisI C Hasselbalch, H B Søndergaard, N Koch-Henriksen, et al.
Scandinavian Journal of Infectious Diseases|August 26, 2000
Prognostic value of single measurements of beta-2-microglobulin, immunoglobulin A in HIV disease after controlling for CD4 lymphocyte counts and plasma HIV RNA levelsH Ullum, A C Lepri, T L Katzenstein, et al.
Scandinavian Journal of Immunology|May 13, 1999
Immunological changes in human immunodeficiency virus (HIV)-infected individuals during HIV-specific protease inhibitor treatmentH Ullum, T Katzenstein, H Aladdin, et al.
Blood|December 9, 2000
Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infectionN Sidenius, C F Sier, H Ullum, et al.
Scandinavian Journal of Immunology|January 13, 2011
Soluble urokinase plasminogen activator receptor during allogeneic stem cell transplantationE Haastrup, J Andersen, S R Ostrowski, et al.
Journal of Acquired Immune Deficiency Syndromes|November 1, 1994
The effect of acute exercise on lymphocyte subsets, natural killer cells, proliferative responses, and cytokines in HIV-seropositive personsH Ullum, J Palmø, J Halkjaer-Kristensen, et al.
AIDS (London, England)|October 9, 1998
The relative prognostic value of plasma HIV RNA levels and CD4 lymphocyte counts in advanced HIV infectionA Cozzi Lepri, T L Katzenstein, H Ullum, et al.
Pageof 8

Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
HIV Medicine|January 22, 2003
Virological and immunological profiles among patients with undetectable viral load followed prospectively for 24 monthsT L Katzenstein, H Ullum, B T Røge, et al.
HIV Medicine|July 10, 2018
Association between smoking status assessed with plasma-cotinine and inflammatory and endothelial biomarkers in HIV-positive and HIV-negative individualsM G Ahlström, A Knudsen, H Ullum, et al.
BMC Infectious Diseases|October 27, 2009
Downregulation of MIP-1alpha/CCL3 with praziquantel treatment in Schistosoma haematobium and HIV-1 co-infected individuals in a rural community in ZimbabweRbl Zinyama-Gutsire, E Gomo, P Kallestrup, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 6, 2018
The neutrophil-to-lymphocyte ratio is associated with multiple sclerosisI C Hasselbalch, H B Søndergaard, N Koch-Henriksen, et al.
Scandinavian Journal of Infectious Diseases|August 26, 2000
Prognostic value of single measurements of beta-2-microglobulin, immunoglobulin A in HIV disease after controlling for CD4 lymphocyte counts and plasma HIV RNA levelsH Ullum, A C Lepri, T L Katzenstein, et al.
Scandinavian Journal of Immunology|May 13, 1999
Immunological changes in human immunodeficiency virus (HIV)-infected individuals during HIV-specific protease inhibitor treatmentH Ullum, T Katzenstein, H Aladdin, et al.
Blood|December 9, 2000
Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infectionN Sidenius, C F Sier, H Ullum, et al.
Scandinavian Journal of Immunology|January 13, 2011
Soluble urokinase plasminogen activator receptor during allogeneic stem cell transplantationE Haastrup, J Andersen, S R Ostrowski, et al.
Journal of Acquired Immune Deficiency Syndromes|November 1, 1994
The effect of acute exercise on lymphocyte subsets, natural killer cells, proliferative responses, and cytokines in HIV-seropositive personsH Ullum, J Palmø, J Halkjaer-Kristensen, et al.
AIDS (London, England)|October 9, 1998
The relative prognostic value of plasma HIV RNA levels and CD4 lymphocyte counts in advanced HIV infectionA Cozzi Lepri, T L Katzenstein, H Ullum, et al.
Pageof 8